Regeneron Pharmaceuticals (REGN) was upgraded to a 'Buy' recommendation today by TheStreet.com's quantitative service. Let's check and see if the technical approach and the quantitative approach are on the same page.
More from Investing
There is little for prudent market players to do but to stay with the trend, even if it feels silly to do so.
We will anticipate, that's how the market works. No matter how we spin it those are anticipatory moves.
It's interesting how much the charts have changed in six months or so.
The banks have the ability to determine much of what's real and what's phony, more than any other group.